CytoSorbents Corporation
(NASDAQ : CTSO)

( )
CTSO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.15%78.360.6%$440.98m
ABTAbbott Laboratories
0.59%56.330.8%$367.45m
BDXBecton, Dickinson and Company
1.19%211.861.3%$227.57m
TMOThermo Fisher Scientific Inc.
0.70%193.791.0%$225.78m
ISRGIntuitive Surgical, Inc.
3.39%369.582.5%$211.34m
ALGNAlign Technology, Inc.
2.03%200.856.3%$172.99m
DXCMDexCom, Inc.
-0.45%44.788.7%$162.60m
SYKStryker Corporation
0.78%150.481.3%$157.80m
XRAYDENTSPLY International Inc.
1.93%61.843.0%$134.96m
ZBHZimmer Biomet Holdings, Inc.
0.36%122.321.7%$133.04m
EWEdwards Lifesciences Corporation
1.05%113.211.2%$132.84m
BCRC. R. Bard, Inc.
0.51%328.981.6%$127.30m
BAXBaxter International Inc.
0.17%63.581.7%$127.26m
BSXBoston Scientific Corporation
0.44%29.701.1%$121.43m
COOCooper Companies, Inc.
-0.31%235.342.2%$118.57m

Company Profile

CytoSorbents Corp. engages in the development blood purification technology for the reduction of deadly uncontrolled inflammation in hospitalized patients. Its product, CytoSorb, is a extracorporeal cytokine filter and seeks to reduce cytokine storm that could otherwise cause massive inflammation, organ failure, and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.